Search Results

GPCR Podcast << Back to podcast list Dr. Aurélien Rizk About Dr. Aurélien Rizk "Dr. the company's ability to predict the residence time of a ligand and its potential correlation with a therapeutic Therapeutic Effect and Receptor Interactions Aurelien Rizk and Yamina had a detailed discussion about the importance of gaining more information about the therapeutic effect in patients or animals and the They also shared their preference for small molecule therapies over protein therapeutics.

Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program

GPCR Podcast << Back to podcast list Dr. Aaron Sato About this episode In this episode of the Dr. GPCR Podcast , I spoke to Dr. record as a biologics leader as he led teams to discover and develop novel first-in-class antibody therapeutics GPCR podcast. Dr. GPCR Ecosystem Thanks for listening to this podcast episode This short survey will help us understand

GPCR Ecosystem and collaborate with us to make a positive impact.

Retreat 2023 About Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to clinical stage company developing next generation immunotherapies, and member of the SAB of Domain Therapeutics , a biopharmaceutical company focused on GPCR in immuno-oncology." GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires 22nd GPCR Retreat Sponsored by

GPCR Podcast << Back to podcast list Dr. Stephen Ferguson The History of the Great Lakes GPCR Retreat with Dr. Stephen Ferguson About Dr. Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994). GPCR Ecosystem Great Lakes GPCR Retreat on the web 21st Great Lakes GPCR Retreat More about previous GPCR Retreat meetings Dr.

GPCR Podcast << Back to podcast list Nicole Perry-Hauser About Nicole (Nicki) Perry-Hauser I am a postdoctoral build a productive, independent scientific research career in adhesion G protein-coupled receptor (aGPCR Mutations in aGPCRs have been linked to various neuropsychiatric phenotypes, and my work will provide a basis for understanding aGPCR biology in the nervous system. GPCR Ecosystem Thanks for listening to this podcast episode This short survey will help us understand

Retreat 2023 About Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to He is a world-renowned expert in the field of cell signaling and GPCRs and made seminal contributions of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires 22nd GPCR Retreat Sponsored by

GPCR Podcast << Back to podcast list Dr. Prasenjit Saha About Dr. Specifically, I am interested in understanding dysregulated G-protein coupled receptor (GPCR) signaling receptors would be a significant breakthrough in cardiovascular biology as they could be targeted for therapeutic My long-term plan is to conduct research in the field of receptor biology, with a focus on GPCRs. GPCR Thanks for listening to this podcast episode This short survey will help us understand your needs

Retreat 2023 About Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Removing the GPCR-mediated brake on exocytosis enhances insulin action, promotes adipocyte The Department’s strengths lie in GPCR signal transduction and neuroscience, and she has expanded it GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires 22nd GPCR Retreat Sponsored by

GPCR Podcast << Back to podcast list Dr. He continues to pioneer in drug discovery studying GPCRs and other target classes. His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics I sat down with Brian to chat about GPCRs, working in the industry, and being a leader. GPCR Ecosystem Thanks for listening to this podcast episode This short survey will help us understand

GPCR Podcast << Back to podcast list Dr. He continues to pioneer in drug discovery studying GPCRs and other target classes. His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics I sat down with Brian to chat about GPCRs, working in the industry, and being a leader. GPCR Ecosystem Thanks for listening to this podcast episode This short survey will help us understand

GPCR Podcast << Back to podcast list Dr. Stuart Maudsley About Dr. At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based therapeutics that interdict diseases based on their gerontological underpinnings. GPCR Ecosystem Thanks for listening to this podcast episode This short survey will help us understand

GPCR Podcast << Back to podcast list Dr. Stuart Maudsley About Dr. At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based therapeutics that interdict diseases based on their gerontological underpinnings. GPCR Ecosystem Thanks for listening to this podcast episode This short survey will help us understand

GPCR Podcast << Back to podcast list Dr. Stuart Maudsley About Dr. At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based therapeutics that interdict diseases based on their gerontological underpinnings. GPCR Ecosystem Thanks for listening to this podcast episode This short survey will help us understand

GPCR Podcast << Back to podcast list Exploring Career Paths in GPCR Research with Dr. In future talks and interviews, Jacek will share his stories and advice about GPCRs. Yamina will schedule a future talk with Jacek about GPCRs as therapeutic modalities. their research interests and achievements, particularly in the field of GPCR. The discussion revealed their interest in GPCRs as therapeutic modalities and possible future collaborations

GPCR Podcast << Back to podcast list Yao Lu (Jackie) About Yao Lu (Jackie) "Jackie is a Ph.D. student molecular explanation of small molecules for their pre-clinical efficacy and to support the design of novel therapeutics GPCR Thanks for listening to this podcast episode This short survey will help us understand your needs

GPCR Podcast << Back to podcast list Dr. Kevin Pfleger About this episode Dr. I sat down with Kevin to chat about GPCRs, pharmacology, and his contributions to the field in both the binding and function at the molecular and cellular levels over the last 20 years, particularly involving GPCRs Institute of Medical Research, Deputy Director of the Australian Research Council Centre for Personalised Therapeutics GPCR Ecosystem Thanks for listening to this podcast episode This short survey will help us understand

Michael Feigin is an Associate Professor in the Department of Pharmacology and Therapeutics, and Director of Graduate Studies of Experimental Therapeutics at Roswell Park Comprehensive Cancer Center in Buffalo GPCR Targeted Drugs and Gene Regulation in Cancer Cells Mike presented research on the effect of GPCR-targeted disrupting histone processing on rapidly proliferating cells, such as cancer cells, and suggested a therapeutic GPCRs and Cancer Immune Modulation Yamina and Mike had a discussion about their research on GPCRs, specifically

GPCR Podcast << Back to podcast list Dr. Timo De Groof About Dr. Timo De Groof Dr. , while also focusing on their therapeutic potential in oncology and transplant infectious disease. In the near future, Timo hopes to combine his previous GPCR experience with his current focus to set up his own research line focusing on translational applications of GPCR-targeting nanobodies. GPCR Ecosystem Thanks for listening to this podcast episode This short survey will help us understand

GPCR Ecosystem website. Get the information you need to create engaging and impactful content. GPCR, Ecosystem.DrGPCR.com, DrGPCR.com. 1.

GPCR Podcast << Back to podcast list Tanishka S. Saraf About Tanishka S. Saraf " My research focuses on evaluating and targeting serotonin 1A receptors for therapeutic outcomes GPCR Thanks for listening to this podcast episode This short survey will help us understand your needs

Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics They explored the evolution of the field, allosteric modulation concepts, and potential therapeutic approaches Arthur will work on designing ligands for specific receptors, aiming to create biased agonists for therapeutic Yamina discussed the potential of autoantibodies and allosteric modulation in the context of disease and therapeutic endogenous allosteric ligands and the possibility of using a neutral allosteric ligand as a preferred therapeutic

GPCR Podcast << Back to podcast list The Role of Quantitative Sciences in GPCRs with Dr. She has advanced the use of computational methods to meet the challenges of designing therapeutics with GPCR Thanks for listening to this podcast episode This short survey will help us understand your needs

GPCR Podcast << Back to podcast list Dr. GPCR podcast , we meet with Dr. Amynah Pradhan. Andrew Charles that who specialized in animal models of migraine and delta-opioid receptors as a therapeutic GPCR Ecosystem Thanks for listening to this podcast episode This short survey will help us understand

GPCR Podcast << Back to podcast list Dr. Lauren M. Slosky About Dr. Lauren M. Slosky’s research is focused on understanding how neuropeptide G protein-coupled receptors (GPCRs) regulate motivated behavior and how these receptors can be targeted for therapeutic benefit. distinct signaling pathways with their physiological effects and may serve as the basis for more selective therapeutics Integrating GPCR biology, behavioral pharmacology, and systems neuroscience approaches, the Slosky Lab

GPCR Podcast << Back to podcast list Chris Langmead Chris Langmead is Professor, Deputy Director, and collaborative neuroscience R&D program with Servier (France) and is the co-founder and CEO of Phrenix Therapeutics , a biotech spin-out from the Neuromedicines Discovery Centre that is developing next-generation therapeutics Prior to these roles this he was Head of Pharmacology at Heptares Therapeutics Ltd., a UK-based biotechnology These successes enabled the US$400M sale of Heptares Therapeutics Ltd. to the Sosei Group Corporation

GPCR Podcast << Back to podcast list Dr. Michel Bouvier About Dr. He is a world-renowned expert in the field of cell signaling and GPCRs and made seminal contributions of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics been able to work with him and his team and use the tools developed in his lab to better understand GPCR GPCR Ecosystem Thanks for listening to this podcast episode This short survey will help us understand